Bixiye
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 2631 - 2640 ee natiijooyinka 4130
Bixiye
Compounded Medications - Commercial
Formulary Exception, Coverage Exception
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Anti-Influenza Agents - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
QP75-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Weight Loss Agents
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP73-21 Medical Drug Update – RSV Health Alert and Palivizumab (Synagis)
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP74-21 Chantix Recall and Shortage
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP72-21 Commercial and MHCP Pharmacy Benefit Exclusion for Saphnelo
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP71-21 Provider Sharing of Protected Health Information (PHI) with Care Coordinators for Minnesota Health Care Program Members
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
Triptan - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025